Spots Global Cancer Trial Database for relapse free survival in 2 years
Every month we try and update this database with for relapse free survival in 2 years cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Gefitinib for EGFR Sensitive Mutation Postoperative Stage Ib NSCLC Patients | NCT02526537 | NSCLC | 18 Years - 78 Years | West China Hospital |